Definium Therapeutics, Inc. (DFTX)
34.70
-0.39
(-1.11%)
USD |
NASDAQ |
Oct 08, 14:26
Definium Therapeutics Market Cap : 4.663B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 4.715B |
| October 06, 2026 | 4.786B |
| October 05, 2026 | 4.868B |
| October 02, 2026 | 5.025B |
| October 01, 2026 | 5.052B |
| September 30, 2026 | 5.114B |
| September 29, 2026 | 5.134B |
| September 28, 2026 | 5.161B |
| September 25, 2026 | 4.860B |
| September 24, 2026 | 4.935B |
| September 23, 2026 | 5.059B |
| September 22, 2026 | 5.418B |
| September 21, 2026 | 5.278B |
| September 18, 2026 | 5.215B |
| September 17, 2026 | 5.197B |
| September 16, 2026 | 5.086B |
| September 15, 2026 | 4.947B |
| September 14, 2026 | 5.408B |
| September 11, 2026 | 5.225B |
| September 10, 2026 | 5.070B |
| September 09, 2026 | 5.105B |
| September 08, 2026 | 5.137B |
| September 04, 2026 | 5.118B |
| September 03, 2026 | 5.106B |
| September 02, 2026 | 5.227B |
| Date | Value |
|---|---|
| September 01, 2026 | 5.173B |
| August 31, 2026 | 5.337B |
| August 28, 2026 | 5.506B |
| August 27, 2026 | 5.888B |
| August 26, 2026 | 5.881B |
| August 25, 2026 | 6.021B |
| August 24, 2026 | 5.814B |
| August 21, 2026 | 6.034B |
| August 20, 2026 | 6.100B |
| August 19, 2026 | 6.157B |
| August 18, 2026 | 6.205B |
| August 17, 2026 | 6.081B |
| August 14, 2026 | 5.728B |
| August 13, 2026 | 5.899B |
| August 12, 2026 | 5.750B |
| August 11, 2026 | 5.497B |
| August 10, 2026 | 6.067B |
| August 07, 2026 | 6.200B |
| August 06, 2026 | 6.200B |
| August 05, 2026 | 5.965B |
| August 04, 2026 | 5.686B |
| August 03, 2026 | 4.348B |
| July 31, 2026 | 4.528B |
| July 30, 2026 | 4.629B |
| July 29, 2026 | 4.387B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enliven Therapeutics, Inc. | 2.962B |
| Cocrystal Pharma, Inc. | 14.62M |
| CNBX Pharmaceuticals, Inc. | 0.2361M |
| Arvinas, Inc. | 491.06M |
| Fulcrum Therapeutics, Inc. | 285.31M |
Market Cap Related Metrics
| PEG Ratio | -0.0748 |
| Price to Book Value | 5.075 |
| Price | 34.70 |
| Earnings Yield | -9.91% |
| PEGY Ratio | -0.0748 |